Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC

Aim: Intravesical Bacillus Calmette–Guérin (BCG) is the standard therapy for non-muscle invasive bladder cancer (NMIBC); however, many patients experience recurrence or progression. We examined how urinary immune signals and the urinary microbiome change across BCG and are related to outcomes. Metho...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Yuki Oda, Makito Miyake, Nobutaka Nishimura, Takuto Shimizu, Takuya Owari, Kota Iida, Yasushi Nakai, Nobumichi Tanaka, Kiyohide Fujimoto
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Open Exploration Publishing Inc. 2026-04-01
Цуврал:	Exploration of Targeted Anti-tumor Therapy
Нөхцлүүд:	bacillus calmette–guérin (bcg) therapy non-muscle invasive bladder cancer urinary immune profiling urinary microbiome dynamics firmicutes/bacteroidetes ratio progression-free survival
Онлайн хандалт:	https://www.explorationpub.com/uploads/Article/A1002365/1002365.pdf
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!